HOPE
@psychedelethics
Hub @UniofOxford for Psychedelic Ethics (HOPE). News & info on ethics, law & social policy of psychedelics. Led by @briandavidearp @ExistWell via @OxNeuroEthics
New publication, in press 🚨Psychedelics Beyond Medicine: Treatment, Enhancement, Hype, Consent, and the Limits of Medicalization - led by @Katherine_Chg, Mina Caraccio, Sebastian Porsdam Mann, with @ExistWell @psychedelethics and others in @JournalPHP researchgate.net/publication/39…
With @CaleighPropes, @MariannaGrazz, Kyle Patch & @ExistWell, we reviewed ICDs from psilocybin clinical trials across the U.S., and provided a systematic qualitative description of these ICDs.
New paper thread! 🧵 Many have called for “enhanced” informed consent documents (ICD) for psychedelic research & treatments, with growing calls for tailored ICDs in the psychedelic bioethics lit. But how closely do ICDs in psychedelic clinical trials reflect these proposals?
📚✨ ~500 Papers. ~30 Researchers & Experts. One Annotated Psychedelics Bibliography... Introducing the 2024 edition of Psychedelic Alpha's Interdisciplinary Annotated Psychedelic Research Bibliography, by @MichaelHaichin. psychedelicalpha.com/news/the-inter…
Do you have experience with psychedelic integration? Share your knowledge and experiences in the anonymous questionnaires below to help advance our understanding of how to promote healing, growth, and transformation through psychedelic integration. psychedelicintegrationstudies.com
We’re excited to welcome Lucy Frith, Brian D. Earp & Arianne Shahvisi as our new joint EiCs! As leading experts in #bioethics & #medicalethics, their collective leadership promises to shape the journal’s future with intellectual rigor, inclusivity & innovation. Learn more about…
New paper 🧵! @r_ehrenkranz, @ExistWell & I explore investigator-level biases in psychedelic clinical trials, & measures that have been proposed to mitigate them. We advocate for 4 additional measures that we believe may be particularly beneficial for the field to implement
An aficionado of the hype cycle—and, for that matter, the post-hype comedown—associated with promising new mental health treatments, Raison is perhaps uniquely positioned to weigh in on the current state and future prospects of psychedelics in mainstream psychiatry...
Hope, Hype, and Humility: Dr. Charles Raison Reflects on Psychedelics’, and Psychiatry’s, Wild Ride psychedelicalpha.com/news/hope-hype…
As the field progresses, we argue that psychedelic research can work towards improving its rigor and transparency by adopting Open Science practices, as well as learning from methods that have been applied in other settings (e.g. in industry-sponsored trials) to mitigate bias.
CPCR faculty David Yaden (@ExistWell) spoke with Johns Hopkins Medicine (@HopkinsMedicine) to discuss evidence-based messaging about psychedelic research, informed consent, and adverse events surveillance.
New in Research Ethics: "Enhanced independence: De-biasing processes in psychedelic research and beyond" RCTs aren't immune to bias—and perceived bias in psychedelic trials is an issue. @Katherine_Chg @r_ehrenkranz @existwell propose 4 independence-enhancing practices: -…
New paper 🧵! @r_ehrenkranz, @ExistWell & I explore investigator-level biases in psychedelic clinical trials, & measures that have been proposed to mitigate them. We advocate for 4 additional measures that we believe may be particularly beneficial for the field to implement
Enhanced independence: De-biasing processes in psychedelic research and beyond - Katherine Cheung, Rebecca Ehrenkranz, David B. Yaden, 2025 journals.sagepub.com/doi/10.1177/17…
Working on getting a bibliography of sorts for psychedelic ethics/philosophy papers together - sharing in case it comes in useful for anyone else! Ongoing project & please feel free to let me know if I've missed something 🌿 katcheung.com/psychedelic-et…
Excited to have a piece coming out with a 90 year update on my grandfather’s work - check this out:
We’re happy to share HOPE’s (@psychedelethics) response to the PATH Caucus’s Request for Information (RFI) on psychedelics. Our response, linked below, highlights key considerations for the field. @Katherine_Chg, @CaleighPropes, @eddietalksdrugs, @briandavidearp, & @ExistWell
Link to our Response here: researchgate.net/publication/38…
We hope that establishment of the PSSC will help to unify the field, reduce regulatory inconsistencies, and facilitate the safe integration of psychedelics into mainstream healthcare.
We thus call for: 1) The establishment of a Psychedelic Standards and Solutions Committee (PSSC), to develop national standards and guidelines 📝 2) Enhanced federal support in the form of NIH & other governmental funding to help drive sustainable progress & rigorous research 🔬